Cargando…
Real-world data on the survival outcome of patients with newly diagnosed Waldenström macroglobulinemia
BACKGROUND/AIMS: Waldenström macroglobulinemia (WM) is a rare lymphoproliferative disorder that usually follows an indolent clinical course. However, some patients show an aggressive clinical course leading to death. We explored the risk factors predicting poor prognosis in WM patients. METHODS: We...
Autores principales: | Cho, Jang Ho, Shim, Joon-Ho, Yoon, Sang Eun, Kim, Hee-Jin, Kim, Sun-Hee, Ko, Young Hyeh, Lee, Seung-Tae, Kim, Kihyun, Kim, Won Seog, Kim, Seok Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137404/ https://www.ncbi.nlm.nih.gov/pubmed/32791817 http://dx.doi.org/10.3904/kjim.2019.367 |
Ejemplares similares
-
Detection of MYD88 L265P in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia and other B-cell non-Hodgkin lymphomas
por: Shin, Sang-Yong, et al.
Publicado: (2016) -
Clinical Factors Associated with Response or Survival after Chemotherapy in Patients with Waldenström Macroglobulinemia in Korea
por: Lee, Ho Sup, et al.
Publicado: (2014) -
Therapeutic Experience of Bing-Neel Syndrome Associated with Waldenstrom's Macroglobulinemia
por: Kim, Hyun Do, et al.
Publicado: (2007) -
Intensely Pruritic Papules and Plaques in Waldenstrom's Macroglobulinemia
por: Lee, Solam, et al.
Publicado: (2018) -
Clinical Features of Waldenstrom Macroglobulinemia in Korea
por: Bang, Soo-Mee, et al.
Publicado: (2004)